FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmacology and deals with pharmaceutical composition of arbidol in form of phospholipid nanoparticles with size 8-25 nm, which includes phosphatidylcholine, maltose and arbidol with the following component ratio, wt %: phosphatidylcholine- 20-43%, maltose- 55-78%, arbidol- 2-8%.
EFFECT: composition possesses low toxicity, stability in long-term storage and high bioavailability.
4 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BASED ON BOTANICAL PHOSPHOLIPIDS NANOSYSTEM FOR ACTUATION OF BIOLOGICALLY ACTIVE COMPOUNDS, AND METHOD OF ITS MANUFACTURE (VERSIONS) | 2009 |
|
RU2391966C1 |
| PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
| COMPOSITION FOR DRUG SUBSTANCE INTEGRATION INTO LIPID MATRIX, DRUG COMPOSITION WITH PHOSPHOLIPID FATTY ACID SYSTEM AND METHOD FOR PREPARING THEM | 2011 |
|
RU2463056C1 |
| PHOSPHOLIPID NANOPARTICLE INDOMETACIN APPLICABLE IN OPHTHALMOLOGY | 2011 |
|
RU2456979C1 |
| PHARMACEUTICAL COMPOSITION OF INDOMETACIN INCLUDED IN PHOSPHOLIPID NANOPARTICLES FOR TREATING RHEUMATIC AND INFLAMMATORY DISEASES | 2009 |
|
RU2417079C1 |
| PHOSPHOLIPID COMPOSITION OF ECDISTEN EXHIBITING ADAPTOGENIC AND HEPATOPROTECTIVE ACTIVITY | 2013 |
|
RU2575561C2 |
| COMPOSITION OF DIHYDROQUERCETINE ENCLOSED IN PHOSPHOLIPID NANOPARTICLES | 2013 |
|
RU2536208C1 |
| PHARMACEUTICAL COMPOSITION BASED ON GLUCOCORTICOSTEROID BUDESONIDE AND PHOSPHATIDYLCHOLINE FOR DRY INHALATION | 2019 |
|
RU2730488C1 |
| PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
| LIPID DERIVATIVE OF SARCOLYSIN IN THE COMPOSITION OF PHOSPHOLIPID NANOPARTICLES | 2017 |
|
RU2662086C1 |
